RPG Life Sciences Limited Stock Bombay S.E.

Equities

RPGLIFE

INE105J01010

Pharmaceuticals

Market Closed - Bombay S.E. 06:00:48 2024-05-10 am EDT 5-day change 1st Jan Change
1,448 INR -0.14% Intraday chart for RPG Life Sciences Limited -1.55% +8.38%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2022 4.4B 52.72M Sales 2023 5.13B 61.42M Capitalization 11.58B 139M
Net income 2022 515M 6.17M Net income 2023 676M 8.1M EV / Sales 2022 1.98 x
Net cash position 2022 560M 6.71M Net cash position 2023 832M 9.97M EV / Sales 2023 2.1 x
P/E ratio 2022
18 x
P/E ratio 2023
17.1 x
Employees 1,214
Yield 2022
1.71%
Yield 2023
1.71%
Free-Float 29.34%
More Fundamentals * Assessed data
Dynamic Chart
RPG Life Sciences Limited Seeks Acquisitions CI
Transcript : RPG Life Sciences Limited, Q4 2024 Earnings Call, May 02, 2024
RPG Life Sciences Limited Recommends Equity Dividend for the Year Ended March 31, 2024 CI
RPG Life Sciences Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
RPG Life Sciences Limited Receives an Order from GST Authority, Jaipur, Rajasthan CI
RPG Life Sciences to Acquire 26% Stake in Sunpound Solar MT
Sunpound Solar Private Limited announced that it expects to receive INR 11 million in funding from RPG Life Sciences Limited CI
ICRA Lifts Rating on RPG Life Sciences' Long-term Financing to A+; Shares Jump 3% MT
RPG Life Sciences Limited Announces Order Passed by the Deputy Commissioner of State Tax CI
RPG Life Sciences Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Transcript : RPG Life Sciences Limited, Q2 2024 Earnings Call, Oct 19, 2023
RPG Life Sciences Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
RPG Life Sciences Limited Approves Dividend for the Financial Year Ended March 31, 2023 CI
RPG Life Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
RPG Life Sciences Limited Recommends Payment of Final Dividend for the Financial Year 2022-23 CI
More news
1 day-0.14%
1 week-1.55%
Current month-6.73%
1 month-4.59%
3 months-10.33%
6 months-0.54%
Current year+8.38%
More quotes
1 week
1 415.05
Extreme 1415.05
1 499.95
1 month
1 415.05
Extreme 1415.05
1 592.50
Current year
1 325.00
Extreme 1325
1 740.00
1 year
749.00
Extreme 749
1 740.00
3 years
422.00
Extreme 422
1 740.00
5 years
146.00
Extreme 146
1 740.00
10 years
66.00
Extreme 66
1 740.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 66 15-12-31
Director of Finance/CFO - 20-08-02
Compliance Officer - 11-11-10
Members of the board TitleAgeSince
Chairman 66 08-02-05
Director/Board Member 83 08-02-05
Director/Board Member 60 08-02-05
More insiders
Date Price Change Volume
24-05-10 1,448 -0.14% 1,383
24-05-09 1,450 +0.52% 790
24-05-08 1,443 +1.11% 861
24-05-07 1,427 -1.77% 996
24-05-06 1,453 -1.26% 521

Delayed Quote Bombay S.E., May 10, 2024 at 06:00 am EDT

More quotes
RPG Life Sciences Limited is an India-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has presence in over 10 therapeutic areas, including nephrology, oncology, rheumatology, cardiology, respiratory, nutritional, gastroenterology, and diabetology, among others. The international formulations business is involved in developing, manufacturing and marketing oral solid formulations in the generic and branded generic space across regulated and emerging markets. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Sodium Valproate PR, Nicorandil, Quinfamide, Nicorandil, Haloperidol, Risperidone, and others.
Calendar
More about the company

Annual profits - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW